MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-B and TGF-Β signaling pathways

Oncogene

Volumn 31, Issue 37, 2012, Pages 4150-4163

  Keklikoglou, I ^a   Koerner, C ^a   Schmidt, C ^a   Zhang, J D ^a   Heckmann, D ^a   Shavinskaya, A ^a   Allgayer, H ^a   Guckel B ^b   Fehm, T ^b   Schneeweiss, A ^c   Sahin, O ^a   Wiemann, S ^a   Tschulena, U ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

breast cancer; ER negative; miR 373; miR 520c; NF kappaB; TGF

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA; MICRORNA 373; MICRORNA 520; PARATHYROID HORMONE RELATED PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DOWN REGULATION; EMBRYO; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LYMPH NODE METASTASIS; METASTASIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANGIOPOIETINS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MICRORNAS; NEOPLASM METASTASIS; NF-KAPPA B; PARATHYROID HORMONE-RELATED PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ESTROGEN; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA;

EID: 84866357155     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.571     Document Type: Article

References (58)

1. Bierie B, Moses HL. (2006). TGF-beta and cancer. Cytokine Growth Factor Rev 17: 29-40.
2. Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai SC et al (2003). Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res 63: 290-295. (Pubitemid 36152482)
3. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB et al. (2004). NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101: 10137-10142. (Pubitemid 38891208)
4. Buck MB, Fritz P, Dippon J, Zugmaier G, Knabbe C. (2004). Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients. Clin Cancer Res 10: 491-498. (Pubitemid 38173987)
5. Camp JT, Elloumi F, Roman-Perez E, Rein J, Stewart DA, Harrell JC et al. (2011). Interactions with fibroblasts are distinct in basal-like and luminal breast cancers. Mol Cancer Res 9: 3-13.
6. Chen J, Yao Y, Gong C, Yu F, Su S, Liu B et al. (2011). CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 19: 541-555.
7. Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I et al. (2008). Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 27: 4712-4723.
8. Chen Y, Luo J, Tian R, Sun H, Zou S. (2010). miR-373 negatively regulates methyl-CpG-binding domain protein 2 (MBD2) in Hilar cholangiocarcinoma. Dig Dis Sci 56: 1693-1670.
9. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R et al. (2005). Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP-and HGF-mediated signaling networks. Oncogene 24: 5053-5068. (Pubitemid 41129083)
10. Christofori G. (2006). New signals from the invasive front. Nature 441: 444-450. (Pubitemid 44050139)
11. Esquela-Kerscher A, Slack FJ. (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
12. Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW et al. (2008). Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 105: 13021-13026.
13. Ganapathy V, Ge R, Grazioli A, Xie W, Banach-Petrosky W, Kang Y et al. (2010). Targeting the transforming growth factor-beta pathway inhibits human basal-like breast cancer metastasis. Mol Cancer 9: 122.
14. Gu S, Jin L, Zhang F, Sarnow P, Kay MA. (2009). Biological basis for restriction of microRNA targets to the 30 untranslated region in mammalian mRNAs. Nat Struct Mol Biol 16: 144-150.
15. Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, Binder C. (2004). Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25: 1543-1549. (Pubitemid 39162720)
16. Helbig G, Christopherson 2nd KW, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD et al. (2003). NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638. (Pubitemid 36792563)
17. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S et al. (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210. (Pubitemid 351194050)
18. Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ. (2000). Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60: 5334-5339.
19. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H et al. (2004). NF-kappaB is essential for epithe-lial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581. (Pubitemid 39572107)
20. Iliopoulos D, Hirsch HA, Struhl K. (2009). An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139: 693-706.
21. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39: 493-506.
22. Katsuno Y, Hanyu A, Kanda H, Ishikawa Y, Akiyama F, Iwase T et al. (2008). Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27: 6322-6333.
23. Laurent LC. (2008). MicroRNAs in embryonic stem cells and early embryonic development. J Cell Mol Med 12: 2181-2188.
24. Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH, Lin JT et al. (2009). MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res 315: 2529-2538.
25. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. (1996). Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629. (Pubitemid 26338061)
26. Levy L, Hill CS. (2006). Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17: 41-58. (Pubitemid 43117515)
27. Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
28. Lu Z, Li Y, Takwi A, Li B, Zhang J, Conklin DJ et al. (2011). miR-301a as an NF-kappaB activator in pancreatic cancer cells. EMBO J 30: 57-67.
29. Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C et al. (2009). Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 462: 104-107.
30. Padua D, Massague J. (2009). Roles of TGFbeta in metastasis. Cell Res 19: 89-102.
31. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR et al. (2008). TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77. (Pubitemid 351442989)
32. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T et al. (2007). NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 13: 62-69. (Pubitemid 46067387)
33. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
34. Ren J, Jin P, Wang E, Marincola FM, Stroncek DF. (2009). MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med 7: 20.
35. Schultz N, Marenstein DR, De Angelis DA, Wang WQ, Nelander S, Jacobsen A et al. (2011). Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-beta pathway and reveal microRNA regulation of TGFBR2. Silence 2: 3.
36. Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, Iglehart JD et al. (2007). Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer. Mol Cancer Ther 6: 1973-1982. (Pubitemid 47052487)
37. Sorlie T. (2007). Molecular classification of breast tumors: toward improved diagnostics and treatments. Methods Mol Biol 360: 91-114.
38. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM et al. (1997). Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100: 2952-2960. (Pubitemid 28022831)
39. Spencer KS, Graus-Porta D, Leng J, Hynes NE, Klemke RL. (2000). ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J Cell Biol 148: 385-397. (Pubitemid 30078250)
40. Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY et al. (2004). Human embryonic stem cells express a unique set of microRNAs. Dev Biol 270: 488-498. (Pubitemid 38748567)
41. Taganov KD, Boldin MP, Chang KJ, Baltimore D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486. (Pubitemid 44267285)
42. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR et al. (2003). TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 112: 1116-1124. (Pubitemid 38056326)
43. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
44. Uhlmann S, Zhang JD, Schwager A, Mannsperger H, Riazalhosseini Y, Burmester S et al. (2010). miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29: 4297-4306.
45. van der Horst EH, Leupold JH, Schubbert R, Ullrich A, Allgayer H. (2004). TaqMan-based quantification of invasive cells in the chick embryo metastasis assay. Biotechniques 37: 940-942, 944, 946.
46. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261. (Pubitemid 43271657)
47. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
48. Walter M, Liang S, Ghosh S, Hornsby PJ, Li R. (2009). Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28: 2745-2755.
49. Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q et al. (2006). CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 203: 941-951.
50. Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F et al. (2007). Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 9: 470-478. (Pubitemid 46511081)
51. Weigelt B, Peterse JL, van 't Veer LJ. (2005). Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602. (Pubitemid 41081385)
52. Wu K, Katiyar S, Li A, Liu M, Ju X, Popov VM et al. (2008). Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. Proc Natl Acad Sci USA 105: 6924-6929. (Pubitemid 351754506)
53. Wu N, Liu X, Xu X, Fan X, Liu M, Li X et al. (2011). MiR-373, a novel regulator of PPP6C, functions as an oncogene in hepatocellular carcinoma. FEBS J.
54. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R et al. (1999). TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103: 197-206. (Pubitemid 29053137)
55. Yingling JM, Blanchard KL, Sawyer JS. (2004). Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov 3: 1011-1022. (Pubitemid 39642364)
56. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y et al. (2010). microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci USA 107: 8231-8236.
57. Zhou Z, Connell MC, MacEwan DJ. (2007). TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 19: 1238-1248. (Pubitemid 46561561)
58. Zijlstra A, Mellor R, Panzarella G, Aimes RT, Hooper JD, Marchenko ND et al. (2002). A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific realtime polymerase chain reaction. Cancer Res 62: 7083-7092. (Pubitemid 35424104)